RNA Q4 2022 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+49.5% YoY

Gross Profit

-$43M-1547.2% margin

Operating Income

-$53M-1922.2% margin

Net Income

-$50M-1822.7% margin

EPS (Diluted)

$-0.83

QoQ Revenue Growth

+11.6%

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$40M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$639M

Total Liabilities

$61M

Stockholders' Equity

$578M

Cash & Equivalents

$340M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+49.5%
Gross Profit	-$43M	-$31M	-37.7%
Operating Income	-$53M	-$39M	-38.1%
Net Income	-$50M	-$39M	-31.0%